Herbalife Mum On ‘Attacks’ As It Trumpets ‘Foundation’ For Growth
This article was originally published in The Tan Sheet
Executive Summary
The direct seller, reporting its first-quarter earnings, also notes a bank’s “vote of confidence” in extending the maturity date of its revolving credit facility. Its adjusted net income, due to foreign currency impact, was down 28% to $108.8 million, or $1.29 EPS.
You may also be interested in...
Herbalife Claims No Harm, But FTC Hails 'Unprecedented' Settlement's Impact
In addition to imposing a $200m fine, the settlement requires the direct seller to determine compensation for its distributors based on actual retail sales, rather than on the number of additional distributors they bring into their networks, and to show at least 80% of its revenues are to end-users.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.